Ha William N, Kahler Bill, Walsh Laurence J
School of Dentistry, University of Queensland, Brisbane, Australia.
Eur Endod J. 2017 Jan 13;2(1):1-6. doi: 10.5152/eej.2017.16053. eCollection 2017.
The purpose of this study was to assess the restorative choices for pulpal therapy by members of the Australian and New Zealand Society of Paediatric Dentistry (ANZSPD).
Members of the ANZSPD were sent an online survey asking about the procedures that they performed and their choice of dental materials.
The respondents were 31 general dentists (GD) and 55 specialist paediatric dentists (PD). Materials used for indirect pulp capping included calcium hydroxide [Ca(OH)] cement (CHC), glass ionomer cement or resin-modified glass ionomer cement (GIC/RMGIC), Ca(OH) paste (CHP) and mineral trioxide aggregate (MTA). Materials for direct pulp capping included MTA, CHP and CHC. Materials and techniques used for pulpotomy included MTA, ferric sulphate, formocresol and diathermy, CHP and CHC. GD and PD were similar in their choice of materials. However, there was no preferred product for pulp therapy. Most GD learnt how to use MTA from CPD lectures, while some PD learnt how to use MTA from their postgraduate training as well as CPD lectures. Many GD and PD did not have hands-on training from their education on how to use MTA (GD: 80%, PD: 43%). Most would like to attend hands-on MTA courses (GD: 86%, PD: 65%).
There was no clear preferred product for the various types of pulp therapy in paediatric dentistry. Education appears to be the major barrier to the use of MTA rather than the cost of MTA.
本研究旨在评估澳大利亚和新西兰儿科牙科学会（ANZSPD）成员在牙髓治疗中的修复选择。
向ANZSPD成员发送了一份在线调查问卷，询问他们所进行的操作以及牙科材料的选择。
受访者包括31名普通牙医（GD）和55名儿科专科牙医（PD）。用于间接盖髓的材料包括氢氧化钙[Ca(OH)]水门汀（CHC）、玻璃离子水门汀或树脂改性玻璃离子水门汀（GIC/RMGIC）、氢氧化钙糊剂（CHP）和三氧化矿物凝聚体（MTA）。用于直接盖髓的材料包括MTA、CHP和CHC。用于牙髓切断术的材料和技术包括MTA、硫酸铁、甲醛甲酚和透热法、CHP和CHC。GD和PD在材料选择上相似。然而，牙髓治疗没有首选产品。大多数GD通过继续职业发展（CPD）讲座学习如何使用MTA，而一些PD则通过研究生培训以及CPD讲座学习如何使用MTA。许多GD和PD在其教育过程中没有接受过关于如何使用MTA的实践培训（GD：80%，PD：43%）。大多数人希望参加MTA实践课程（GD：86%，PD：65%）。
在儿童牙科的各种牙髓治疗中，没有明确的首选产品。教育似乎是使用MTA的主要障碍，而不是MTA的成本。
